310 related articles for article (PubMed ID: 34323194)
21. Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study.
Arbel Y; Birati EY; Finkelstein A; Halkin A; Kletzel H; Abramowitz Y; Berliner S; Deutsch V; Herz I; Keren G; Banai S
Clin Cardiol; 2013 Jun; 36(6):342-6. PubMed ID: 23630016
[TBL] [Abstract][Full Text] [Related]
22. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
Clark DW; Strandell J
Eur J Clin Pharmacol; 2006 Jun; 62(6):473-9. PubMed ID: 16758264
[TBL] [Abstract][Full Text] [Related]
23. Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical Trial and Meta-Analysis.
Alhazzani W; Guyatt G; Alshahrani M; Deane AM; Marshall JC; Hall R; Muscedere J; English SW; Lauzier F; Thabane L; Arabi YM; Karachi T; Rochwerg B; Finfer S; Daneman N; Alshamsi F; Zytaruk N; Heel-Ansdell D; Cook D;
Crit Care Med; 2017 Jul; 45(7):1121-1129. PubMed ID: 28459708
[TBL] [Abstract][Full Text] [Related]
24. A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole.
Labenz J; Petersen KU; Rösch W; Koelz HR
Aliment Pharmacol Ther; 2003 Apr; 17(8):1015-9. PubMed ID: 12694083
[TBL] [Abstract][Full Text] [Related]
25. Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients.
Pilotto A; Franceschi M; Leandro G; Scarcelli C; D'Ambrosio LP; Paris F; Annese V; Seripa D; Andriulli A; Di Mario F
World J Gastroenterol; 2007 Sep; 13(33):4467-72. PubMed ID: 17724802
[TBL] [Abstract][Full Text] [Related]
26. Pantoprazole-induced thrombocytopenia.
Watson TD; Stark JE; Vesta KS
Ann Pharmacother; 2006 Apr; 40(4):758-61. PubMed ID: 16569810
[TBL] [Abstract][Full Text] [Related]
27. Radiation lethality potentiation in total body irradiated mice by a commonly prescribed proton pump inhibitor, Pantoprazole sodium.
Biju PG; Gubrij I; Garg S; Gupta PK; Hauer-Jensen M; Burnett AF
Int J Radiat Biol; 2014 Jul; 90(7):554-9. PubMed ID: 24646079
[TBL] [Abstract][Full Text] [Related]
28. Anaphylaxis Caused by Taking Pantoprazole: Case Series.
Telaku S; Veliu A; Zenelaj Q; Telaku M; Fejza H; Alidema F
Eur J Case Rep Intern Med; 2023; 10(9):004017. PubMed ID: 37680781
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
Andersson T
Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
[TBL] [Abstract][Full Text] [Related]
30. A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole.
Schepp W; Rehner M; Witzel L
Aliment Pharmacol Ther; 1994; 8 Suppl 1():53-7. PubMed ID: 8180295
[TBL] [Abstract][Full Text] [Related]
31. Pantoprazole: a proton pump inhibitor.
Moreira Dias L
Clin Drug Investig; 2009; 29 Suppl 2():3-12. PubMed ID: 19938880
[TBL] [Abstract][Full Text] [Related]
32. A potential risk factor for paraoxonase 1: in silico and in-vitro analysis of the biological activity of proton-pump inhibitors.
Türkeş C
J Pharm Pharmacol; 2019 Oct; 71(10):1553-1564. PubMed ID: 31353473
[TBL] [Abstract][Full Text] [Related]
33. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
Li XQ; Andersson TB; Ahlström M; Weidolf L
Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
[TBL] [Abstract][Full Text] [Related]
34. Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.
Pauli-Magnus C; Rekersbrink S; Klotz U; Fromm MF
Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):551-7. PubMed ID: 11770010
[TBL] [Abstract][Full Text] [Related]
35. Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole.
Nishioka K; Nagao T; Urushidani T
Biochem Pharmacol; 1999 Oct; 58(8):1349-59. PubMed ID: 10487539
[TBL] [Abstract][Full Text] [Related]
36. Safety of proton pump inhibitors--an overview.
Arnold R
Aliment Pharmacol Ther; 1994; 8 Suppl 1():65-70. PubMed ID: 8180297
[TBL] [Abstract][Full Text] [Related]
37. Unexpected cause of Kounis syndrome: hypersensitivity reaction to omeprazole.
Erdem A; Çınar T; Kılıç Ş; Öztürk NB
BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37879707
[TBL] [Abstract][Full Text] [Related]
38. Lessons from two cases of anaphylaxis to proton pump inhibitors.
Choi SW; Han JM; Bae YJ; Lee YS; Cho YS; Moon HB; Kim TB
J Clin Pharm Ther; 2012 Oct; 37(5):614-6. PubMed ID: 22642701
[TBL] [Abstract][Full Text] [Related]
39. Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction.
Fontes-Carvalho R; Albuquerque A; Araújo C; Pimentel-Nunes P; Ribeiro VG
Eur J Gastroenterol Hepatol; 2011 May; 23(5):396-404. PubMed ID: 21464720
[TBL] [Abstract][Full Text] [Related]
40. Anaphylaxis to proton pump inhibitors.
González P; Soriano V; López P; Niveiro E
Allergol Immunopathol (Madr); 2002; 30(6):342-3. PubMed ID: 12464168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
